Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Biomed Pharmacother ; 80: 244-252, 2016 May.
Article in English | MEDLINE | ID: mdl-27133063

ABSTRACT

PURPOSE: Pergularia daemia Forsk. (Asclepiadaceae) is a traditionally reported medicinal herb used to treat joint pain and arthritis. However, there are no scientific reports about anti-arthritic activity of P. daemia methanolic extract on rats as animal model. This study identifies bioactive compounds present in the P. daemia methanolic extract and evaluates its anti-arthritic potential in CFA induced arthritic rats. METHODS AND RESULTS: Phytoconstituents of P. daemia extract were examined using LC-ESI/MS method. Anti-arthritic activity of P. daemia extract was determined by various biochemical experiments (RF, ESR and CRP), ultrasonography and histological analysis. LC-ESI/MS analysis resulted in the identification of major flavonoids compounds such as formononetin, qurecetin, chrysoeriol, taxifolin and naringenin. Serum biomarker analysis, after the treatment with PDME (500mg/kg b.w.) revealed that the hemoglobin (11.84±0.42g/dL) and RBC (8.38±0.67million/mm(3)) levels were significantly increased whereas WBC (8.91±0.38thousands/mm(3)), RF (17.94±0.45IU/mL), ESR (7.91±0.12mm/h) and CRP (22.56±0.26mg/L) levels were decreased when compared with the CFA induced arthritic control group. Histology results revealed that treatment with PDME has resulted in significant prevention against bony destruction by decreasing soft tissue swelling and narrowing of joint spaces (250 and 500mg/kg b.w.). CONCLUSION: Anti-arthritic effect of P. daemia might be due to the presence of these bioactive flavonoids. These findings lend pharmacological support to the reported folkloric use of P. daemia in the treatment and management of painful, arthritic inflammatory conditions.


Subject(s)
Apocynaceae/chemistry , Arthritis, Experimental/drug therapy , Flavonoids/therapeutic use , Plant Extracts/therapeutic use , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Arthritis, Experimental/blood , Arthritis, Experimental/diagnostic imaging , Arthritis, Experimental/pathology , Biomarkers/metabolism , Body Weight/drug effects , Chromatography, Liquid , Extremities/pathology , Female , Flavonoids/chemistry , Flavonoids/pharmacology , Freund's Adjuvant , Hemoglobins/metabolism , Inflammation Mediators/metabolism , Mass Spectrometry , Phytochemicals/analysis , Phytochemicals/chemistry , Phytochemicals/pharmacology , Phytochemicals/therapeutic use , Phytotherapy , Plant Extracts/pharmacology , Rats, Wistar
2.
Int J Pharm ; 457(1): 206-13, 2013 Nov 30.
Article in English | MEDLINE | ID: mdl-24096301

ABSTRACT

We report a simple method to fabricate multifunctional polyelectrolyte thin films to load and deliver the therapeutic drugs. The multilayer thin films were assembled by the electrostatic adsorption of poly (allylamine hydrochloride) (PAH) and dextran sulfate (DS). The silver nanoparticles (Ag NPs) biosynthesized from novel Hybanthus enneaspermus leaf extract as the reducing agent were successfully incorporated into the film. The biosynthesized Ag NPs showed excellent antimicrobial activity against the range of enteropathogens, which could be significantly enhanced when used with commercial antibiotics. The assembled silver nano composite multilayer films showed rupture and deformation when they are exposed to laser. The Ag NPs act as an energy absorption center, locally heat up the film and rupture it under laser treatment. The antibacterial drug, moxifloxacin hydrochloride (MH) was successfully loaded into the multilayer films. The total amount of MH release observed was about 63% which increased to 85% when subjected to laser light exposure. Thus, the polyelectrolyte thin film reported in our study has significant potential in the field of remote activated drug delivery, antibacterial coatings and wound dressings.


Subject(s)
Anti-Bacterial Agents/chemistry , Aza Compounds/chemistry , Drug Delivery Systems , Metal Nanoparticles/chemistry , Quinolines/chemistry , Silver/chemistry , Violaceae , Amoxicillin-Potassium Clavulanate Combination/chemistry , Amoxicillin-Potassium Clavulanate Combination/pharmacology , Anti-Bacterial Agents/pharmacology , Aza Compounds/pharmacology , Bacteria/drug effects , Dextran Sulfate/chemistry , Erythromycin/chemistry , Erythromycin/pharmacology , Fluoroquinolones , Lasers , Moxifloxacin , Plant Extracts/chemistry , Plant Leaves , Polyamines/chemistry , Quinolines/pharmacology , Silver/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL